Participants were randomly allocated to standard HoLEP, single-n technology, and innovative double-n technology (groups A, B, and C, respectively). A total of 139 participants completed the study.

Andromeda Surgical, a leading innovator in robotic-assisted surgery, is proud to announce strategic partnerships with Richard Wolf and Quanta System, two global leaders in medical technology. These ...